I agree that this site is using cookies. You can find further informations here.
X
Vallatharasu, Yazhini
10  results:
Search for persons X
?
1

Utilization of Surgery and Its Impact on Survival in Patien..:

Uprety, Dipesh ; Arjyal, Lubina ; Vallatharasu, Yazhini...
Clinical Lung Cancer.  21 (2020)  2 - p. 186-193.e2 , 2020
Link: https://doi.org/10.1016/..
 
?
2

Sequential treatment failures in response to BRAF/MEK and i..:

Richmond, Craig S. ; Vallatharasu, Yazhini ; Deviley, Jake A....
Experimental and Molecular Pathology.  110 (2019)  - p. 104260 , 2019
Link: https://doi.org/10.1016/..
 
?
3

Durable Response After 2 Doses of Pembrolizumab in a Patien..:

Uprety, Dipesh ; Arjyal, Lubina ; Vallatharasu, Yazhini...
Clinical Lung Cancer.  20 (2019)  5 - p. e552-e554 , 2019
Link: https://doi.org/10.1016/..
 
?
4

Severe, prolonged thrombocytopenia in a patient sensitive t..:

Vallatharasu, Yazhini ; Hayashi‐Tanner, Yacki ; Polewski, Peter J....
American Journal of Hematology.  94 (2018)  3 - p. , 2018
Link: https://doi.org/10.1002/..
 
?
5

Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Dr..:

Lashari, Bilal H. ; Vallatharasu, Yazhini ; Kolandra, Lakshmi..
Drugs in R&D.  18 (2018)  4 - p. 255-258 , 2018
Link: https://doi.org/10.1007/..
 
?
6

The Role of Osimertinib in Treatment Naïve Epidermal Growth..:

Uprety, Dipesh ; Bista, Amir ; Vallatharasu, Yazhini.
Clinical Medicine Insights: Oncology.  12 (2018)  - p. 117955491877958 , 2018
Link: https://doi.org/10.1177/..
 
?
7

Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Dr..:

Lashari, Bilal H ; Vallatharasu, Yazhini ; Kolandra, Lakshmi..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277321/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
8

SEVERE, PROLONGED THROMBOCYTOPENIA IN A PATIENT SENSITIVE T..:

Vallatharasu, Yazhini ; Hayashi-Tanner, Yacki ; Polewski, Peter J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942234/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
9

The Role of Osimertinib in Treatment Naïve Epidermal Growth..:

Dipesh Uprety ; Amir Bista ; Yazhini Vallatharasu.
https://doi.org/10.1177/1179554918779585.  , 2018
Link: https://doi.org/10.1177/..
 
?
10

Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Dr..:

Bilal H. Lashari ; Yazhini Vallatharasu ; Lakshmi Kolandra..
http://link.springer.com/article/10.1007/s40268-018-0247-7.  , 2018
Link: https://doi.org/10.1007/..
 
1-10